Podcast - A Post-Election Checkup: FDA Policy and Regulation

In this post-election special edition episode of our Public Policy & Regulation Group's "The Eyes on Washington" podcast series, healthcare attorneys Sara Klock and Michael Werner discuss how the elections will impact the U.S. Food and Drug Administration (FDA) and what can be expected in terms of agency regulation and related legislation. The conversation takes an in-depth look at FDA's stance on digital health products, cannabis and laboratory developed tests. Our hosts also express that the industry should be prepared for an uptick in enforcement and explain how Holland & Knight guides clients through the regulation process.

More Episodes in this Series

Episode 1: Don't Let Your Monkeys Become Gorillas: Congressional Oversight Post-Midterms

Episode 2: Let's Get Fiscal: Election Impacts on Tax Code

Episode 3: Election Impacts on DOE Funding, Clean Tech Legislation and Energy Innovation

Episode 4: Both Sides of the Aisle: Education Policy Agenda in the 118th Congress

Episode 5: COP27 in Review: It Takes a Village

Episode 6: An Update on the General Energy and Climate Legislative Landscape

Episode 7: A Post-Election Checkup: FDA Policy and Regulation (You are currently viewing Episode 7)

Episode 8: Where to Next? Transportation and Infrastructure Priorities in the 118th Congress

Listen to more episodes of The Eyes on Washington Podcast here.